- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02130089
Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?
January 26, 2016 updated by: Alison Steiber, Academy of Nutrition and Dietetics
The purpose of this project is to understand if more frequent education of dialysis patients (patients with kidney failure who get their blood cleaned and fluid removed by a machine instead of their kidneys) on reducing sodium intake reduces the amount of fluid weight that patients gain between dialysis sessions.
Patients who usually gain more fluid than is considered ideal will be recruited for this project.
Because all patients gain different amounts to start, data will be collected for 3 months while the patients receive their usual amount of dietitian education.
Then the patients will receive intensive (2x/month) education on reducing sodium intake from the dietitian and the same data will be collected to see if they gain less after the education.
After 3 months of intensive education, data will be collected for one more month to see if patients keep gaining less or if they go back to their old patterns.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Auckland, New Zealand
- Auckland Board of Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Average Interdialytic weight gain (IDWG) for 2 weeks prior to screening period greater than or equal to 4% estimated dry weight
- Able to sign the locally approved informed consent
- Willing to receive dietitian education on sodium and fluid control during normal dialysis time
- Receiving thrice weekly maintenance hemodialysis for greater than or equal to 6 months Age greater than or equal to 18 years
Exclusion Criteria:
- On hospice or international equivalent
- Receiving corticosteroid treatment
- Less than 18 years old
- On interdialytic parenteral nutrition
- Transfer to another facility expected within 3 months
- Severe malnutrition, as assessed by Subjective Global Assessment (SGA) or other standard assessment tool
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: All patients
Intensive tailored education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Average Percent Interdialytic Weight Gain
Time Frame: monthly for 7 months
|
monthly for 7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thirst Intensity
Time Frame: monthly for 7 months
|
will be measured by a 100 mm Visual Analog Scale.
Patients are asked to mark the point on the VAS which represents their work thirst since the last dialysis.
Zero is considered no thirst and 100 is extremely thirsty.
This tool has been shown to correlate to the Thirst Distress tool developed by Welsh in 2002.
|
monthly for 7 months
|
Sodium and Fluid Knowledge
Time Frame: Monthly for 4 months
|
Will be assessed using the sodium questions of the tool created by Kim (Korean J Nutr 2001), as modified by Park (J Ren Nutr 2008).
|
Monthly for 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sandra McLellan, Auckland Board of Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
November 1, 2015
Study Registration Dates
First Submitted
April 28, 2014
First Submitted That Met QC Criteria
May 1, 2014
First Posted (Estimate)
May 5, 2014
Study Record Updates
Last Update Posted (Estimate)
January 27, 2016
Last Update Submitted That Met QC Criteria
January 26, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-186
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Disease Requiring Hemodialysis
-
Cubist Pharmaceuticals LLCCompletedEnd-stage Renal Disease | Renal Failure Chronic Requiring HemodialysisUnited States
-
Cendres+MétauxTerminatedHemodialysis Access Failure (Disorder) | End-Stage Renal Disease Requiring HaemodialysisSwitzerland
-
Keryx BiopharmaceuticalsCompletedHyperphosphatemia | End-stage Renal Disease | Renal Failure Chronic Requiring HemodialysisIsrael
-
PfizerCompletedHemodialysis | End-Stage Renal DiseaseUnited States
-
Chulalongkorn UniversityCompletedHemodialysis | End-stage Renal DiseaseThailand
-
University of ManitobaThe Wellness Institute at Seven Oaks General HospitalCompletedEnd-stage Renal Disease | Renal Failure Chronic Requiring HemodialysisCanada
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...CompletedHemodialysis | End-Stage Renal DiseaseUnited States
-
Children's Hospital of PhiladelphiaThe Hospital for Sick Children; Children's Hospital Medical Center, CincinnatiCompletedHemodialysis | Pediatric End Stage Renal DiseaseUnited States, Canada
-
Purdue UniversityCompletedHemodialysis | End-Stage Renal Disease | MealsUnited States
-
BayerCompletedEnd Stage Renal Disease Requiring HemodialysisBelgium, United States, Latvia, Taiwan, Germany, Japan, Spain, Canada, Bulgaria, Greece, Ukraine, Czechia, Hungary, Korea, Republic of, Russian Federation
Clinical Trials on Intensive Tailored Education
-
Wake Forest University Health SciencesCompletedHypertension SecondaryUnited States
-
Wake Forest University Health SciencesNot yet recruiting
-
Johns Hopkins Bloomberg School of Public HealthCompleted
-
Taipei Medical UniversityCompleted
-
University Hospitals of North Midlands NHS TrustRecruitingAsthma | Asthma in ChildrenUnited Kingdom
-
National Library of Medicine (NLM)Completed
-
Azienda Ospedaliera Universitaria Integrata VeronaCompleted
-
Duke UniversityCareDxCompletedMedication ComplianceUnited States
-
University of California, DavisKaiser Permanente; VA Northern California Health Care SystemCompleted
-
Griffin HospitalConnecticut Health FoundationCompleted